J. Silvio Gutkind, PhD, is a basic scientist with a passion for exploiting the emerging information on dysregulated signaling circuitries and individual genomic and molecular alterations to identify new therapeutic options to prevent and treat cancer. His lab's basic studies and translational efforts have already made an impact in the development of individualized, mechanism-based molecular-targeted (precision) anticancer treatments and immunotherapeutic strategies.
Dr. Crespo’s research focuses on reducing health disparities and conducting community-based interventions to prevent cardiovascular disease among Latinos and underserved populations. He has experience conducting multi-level and large-scale interventions to promote physical activity and healthy eating in schools and recreation centers. Dr. Crespo also studies the health consequences of sedentary behavior and conducts behavioral interventions to reduce sedentary behavior in worksites.
Hojun Li, MD, PhD, is an Endowed Assistant Professor of Pediatrics at UC San Diego and member of the Hematologic Malignancies research program at Moores Cancer Center. He has been an American Society of Hematology Scholar, a Department of Defense Career Development Independent Fellow, and an NIH Clinical Investigator (K08) Fellow, and has won teaching awards both as a resident and as an attending.
Winta Mehtsun, MD, MPH, is a surgical oncologist whose practice spans gastric cancer, sarcoma, and general surgical oncology. Dr. Mehtsun enjoys helping her patients through a team-based, multi-disciplinary approach to care, and she is an advocate for patients at all stages of their cancer treatment.